New York State Common Retirement Fund Humanigen, Inc Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.76 - $3.33 $39,422 - $74,588	-22,399 Reduced 98.5%	342 $1,000
Q1 2022 May 05, 2022	SELL	$1.81 - $3.97 $38 - $83	-21 Reduced 0.09%	22,741 $68,000
Q4 2021 Feb 02, 2022	SELL	$3.66 - $8.22 $314 - $706	-86 Reduced 0.38%	22,762 $85,000
Q3 2021 Nov 02, 2021	SELL	$5.93 - $17.83 $92,223 - $277,292	-15,552 Reduced 40.5%	22,848 $135,000
Q2 2021 Aug 02, 2021	BUY	$13.54 - $22.74 $519,935 - $873,215	38,400 New	38,400 $667,000

541K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.